Shree Ganesh BioTech India

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue4.124.124.843.932.28
Expenses4.044.044.303.691.96
EBITDA0.080.090.540.240.32
EBIT0.080.090.540.240.32
Profit Before Tax0.080.090.540.240.32
Net Profit0.080.090.540.240.32
Financial Ratios
Operating Profit Margin1.94%2.18%14.29%6.74%16.16%
Net Profit Margin1.94%2.18%14.29%6.74%16.16%
Earning Per Share (Diluted)0.000.000.010.010.01
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ